Search research articles
Contact Us
Filters
Showing results (1-10 of 258) with videos related to
Page
of 26
Sort By:
Cancer Treatment Reports
|
May 1, 1984
Subcutaneous reaction due to intra-arterial infusion of anthracycline
N Jaffe
Clinical Orthopaedics and Related Research
|
September 1, 1991
Recent advances in the chemotherapy of metastatic osteogenic sarcoma. 1972
N Jaffe
Cancer Treatment and Research
|
January 1, 1993
Pediatric osteosarcoma: treatment of the primary tumor with intraarterial cis-diamminedichloroplatinum-II (CDP)--advantages, disadvantages, and controversial issues
N Jaffe
The Orthopedic Clinics of North America
|
July 1, 1989
Chemotherapy for malignant bone tumors
N Jaffe
The American Journal of Pediatric Hematology/Oncology
|
January 1, 1987
Biological consequences of cancer and its treatment and their relationship to current treatment planning
N Jaffe
Pediatric Clinics of North America
|
June 1, 1985
Advances in the management of malignant bone tumors in children and adolescents
N Jaffe
Cancer
|
December 1, 1972
Recent advances in the chemotherapy of metastatic osteogenic sarcoma
N Jaffe
Texas Medicine
|
March 1, 1986
Management of osteosarcoma in children and adolescents
N Jaffe
Clinical Orthopaedics and Related Research
|
January 1, 1976
Osteogenic sarcoma: state of the art with high-dose methotrexate treatment
N Jaffe
Seminars in Oncology
|
March 1, 1977
Metastases in malignant childhood tumors-the role of "adjuvant" therapy and the utility of multidisciplinary treatment
N Jaffe
Page
of 26
Search research articles
Search
Showing results (1-10 of 258) with videos related to
Sort By:
Page
of 26
Cancer Treatment Reports
|
May 1, 1984
Subcutaneous reaction due to intra-arterial infusion of anthracycline
N Jaffe
Clinical Orthopaedics and Related Research
|
September 1, 1991
Recent advances in the chemotherapy of metastatic osteogenic sarcoma. 1972
N Jaffe
Cancer Treatment and Research
|
January 1, 1993
Pediatric osteosarcoma: treatment of the primary tumor with intraarterial cis-diamminedichloroplatinum-II (CDP)--advantages, disadvantages, and controversial issues
N Jaffe
The Orthopedic Clinics of North America
|
July 1, 1989
Chemotherapy for malignant bone tumors
N Jaffe
The American Journal of Pediatric Hematology/Oncology
|
January 1, 1987
Biological consequences of cancer and its treatment and their relationship to current treatment planning
N Jaffe
Pediatric Clinics of North America
|
June 1, 1985
Advances in the management of malignant bone tumors in children and adolescents
N Jaffe
Cancer
|
December 1, 1972
Recent advances in the chemotherapy of metastatic osteogenic sarcoma
N Jaffe
Texas Medicine
|
March 1, 1986
Management of osteosarcoma in children and adolescents
N Jaffe
Clinical Orthopaedics and Related Research
|
January 1, 1976
Osteogenic sarcoma: state of the art with high-dose methotrexate treatment
N Jaffe
Seminars in Oncology
|
March 1, 1977
Metastases in malignant childhood tumors-the role of "adjuvant" therapy and the utility of multidisciplinary treatment
N Jaffe
Page
of 26